<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35790562</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Quality of life and mental health in the locked-in-state-differences between patients with amyotrophic lateral sclerosis and their next of kin.</ArticleTitle><Pagination><StartPage>5910</StartPage><EndPage>5925</EndPage><MedlinePgn>5910-5925</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11238-0</ELocationID><Abstract><AbstractText>For both patients with amyotrophic lateral sclerosis (ALS) and their next of kin (NOK), the maintenance of quality of life (QoL) and mental health is particularly important. First studies suggest significant discrepancies between QoL reports by patients and NOK, but little is known for advanced ALS stages. To address this issue, we screened 52 ALS patients in incomplete locked-in state (iLIS). Final results were obtained for 15 couples of iLIS patients and NOK. We assessed patients' and NOK's subjective QoL, depression and anxiety and NOK's caregiver burden. Gaze controlled questionnaires allowed direct assessment of patients. Patients and NOK self-reported comparable, mostly moderate to high levels of QoL. Of note, NOK indicated stronger anxiety symptoms. Higher anxiety levels in NOK were associated with stronger caregiver burden and reduced QoL. No significant misjudgment of patient's QoL by the NOK was evident, while patients overestimated NOK's global QoL. However, NOK with severe caregiver burden and depression symptoms gave poorer estimations of patients' QoL. This relationship is relevant, considering NOK's impact on life critical treatment decisions. While the daily time NOK and patient spend together was positively correlated with NOK's QoL and mental health, this was not reversely found for the patients. Our results suggest that NOK adapt less successfully to the disease and concomitant experience of loss and point to an urgent need for specialized psychosocial support. The findings emphasize the importance of direct psychological wellbeing assessment of both patients and NOK in clinical practice, enabled by eye-tracking technology for patients in iLIS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aust</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8047-5983</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linse</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graupner</LastName><ForeName>Sven-Thomas</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Engineering Psychology and Applied Cognitive Research, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joos</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Interactive Minds Research, Interactive Minds Dresden GmbH, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebscher</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Interactive Minds Research, Interactive Minds Dresden GmbH, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudlo</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Rostock, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for ALS and other Motor Neuron Disorders, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Humboldt-Universit&#xe4;t zu Berlin, and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pannasch</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Engineering Psychology and Applied Cognitive Research, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, Rostock, Germany. Andreas.Hermann@med.uni-rostock.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, Rostock, Germany. Andreas.Hermann@med.uni-rostock.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht Kossel," Department of Neurology, University Medical Center Rostock, University of Rostock, Gehlsheimer Stra&#xdf;e 20, 18147, Rostock, Germany. Andreas.Hermann@med.uni-rostock.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>13GW0482</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>01VSF16026</GrantID><Agency>Innovationsausschuss beim Gemeinsamen Bundesausschuss</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Caregiver burden</Keyword><Keyword MajorTopicYN="N">End of life decisions</Keyword><Keyword MajorTopicYN="N">Eye tracking</Keyword><Keyword MajorTopicYN="N">Palliative care</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList><CoiStatement>Markus Joos&#x2019; and Daniel Liebscher&#x2019;s affiliation &#x201c;Interactive Minds&#x201d; is a provider of ETCS in the region of Dresden. They were not involved and had no influence in the blinded data analysis. The other authors declare that they have no conflict of interest. Funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>5</Day><Hour>23</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35790562</ArticleId><ArticleId IdType="pmc">PMC9553779</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11238-0</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11238-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>K&#xfc;bler A, Winter S, Ludolph AC, et al. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair. 2005;19:182&#x2013;193. doi: 10.1177/1545968305276583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968305276583</ArticleId><ArticleId IdType="pubmed">16093409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Zickler C, H&#xe4;cker S, et al. Life can be worth living in locked-in syndrome. In: Laureys S, Schiff ND, Owen AM, et al., editors. Progress in brain research. Elsevier; 2009. pp. 339&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">19818912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, Atsuta N, Yokoi D, et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J Neurol Neurosurg Psychiatry. 2020;91:285&#x2013;290. doi: 10.1136/jnnp-2019-322213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322213</ArticleId><ArticleId IdType="pubmed">31937581</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Phil D. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond L, Bowen G, Mertens B, et al. Associations of patient mood, modulators of quality of life, and pharmaceuticals with amyotrophic lateral sclerosis survival duration. Behav Sci. 2020;10:33. doi: 10.3390/bs10010033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bs10010033</ArticleId><ArticleId IdType="pmc">PMC7016647</ArticleId><ArticleId IdType="pubmed">31936812</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach AR, Averill AJ, Segerstrom SC, Kasarskis EJ. The dynamics of quality of life in ALS patients and caregivers. Ann Behav Med. 2009;37:197&#x2013;206. doi: 10.1007/s12160-009-9092-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12160-009-9092-9</ArticleId><ArticleId IdType="pubmed">19350337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilse B, Prell T, Walther M, et al. Relationships between disease severity, social support and health-related quality of life in patients with amyotrophic lateral sclerosis. Soc Indic Res. 2015;120:871&#x2013;882. doi: 10.1007/s11205-014-0621-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11205-014-0621-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter Y, Schepelmann K, Spottke AE, et al. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010;257:1473&#x2013;1481. doi: 10.1007/s00415-010-5549-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5549-9</ArticleId><ArticleId IdType="pubmed">20383521</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandstedt P, Johansson S, Ytterberg C, et al. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269&#x2013;273. doi: 10.1016/j.jns.2016.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.09.034</ArticleId><ArticleId IdType="pubmed">27772773</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert C, Wasner M, Borasio GD. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis. J Palliat Med. 2004;7:551&#x2013;557. doi: 10.1089/jpm.2004.7.551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2004.7.551</ArticleId><ArticleId IdType="pubmed">15353099</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng D, Ou R, Miao X, et al. Patients&#x2019; self-perceived burden, caregivers&#x2019; burden and quality of life for amyotrophic lateral sclerosis patients: a cross-sectional study. J Clin Nurs. 2017;26:3188&#x2013;3199. doi: 10.1111/jocn.13667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.13667</ArticleId><ArticleId IdType="pubmed">27874996</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas PT, Warrier MG, Sadasivan A, et al. Caregiver burden and quality of life of patients with amyotrophic lateral sclerosis in India. Amyotroph Lateral Scler Front Degener. 2018;19:606&#x2013;610. doi: 10.1080/21678421.2018.1482353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1482353</ArticleId><ArticleId IdType="pubmed">30039719</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson BJ, Ozanne AO, Nordin K, Nygren I. A prospective study of quality of life in amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136:631&#x2013;638. doi: 10.1111/ane.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12774</ArticleId><ArticleId IdType="pubmed">28523721</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuz T, Birbaumer N, Hautzinger M, K&#xfc;bler A. Psychosocial adjustment to ALS: a longitudinal study. Front Psychol. 2015;6:1197. doi: 10.3389/fpsyg.2015.01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2015.01197</ArticleId><ArticleId IdType="pmc">PMC4568392</ArticleId><ArticleId IdType="pubmed">26441696</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson AG, Markhede I, Strang S, Persson LI. Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin. Palliat Support Care. 2010;8:75&#x2013;82. doi: 10.1017/S1478951509990733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951509990733</ArticleId><ArticleId IdType="pubmed">20163763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Nonnenmacher S, Sorg S, et al. Live and let die: existential decision processes in a fatal disease. J Neurol. 2014;261:518&#x2013;525. doi: 10.1007/s00415-013-7229-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7229-z</ArticleId><ArticleId IdType="pubmed">24413639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, H&#xe4;cker S, Ludolph A, et al. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch &#xc4;rztebl Int. 2008;105:397&#x2013;403. doi: 10.3238/arztebl.2008.0397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2008.0397</ArticleId><ArticleId IdType="pmc">PMC2696844</ArticleId><ArticleId IdType="pubmed">19626161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons C, Thornton E, Ealing J, et al. The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Front Degener. 2013;14:537&#x2013;545. doi: 10.3109/21678421.2013.799700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.799700</ArticleId><ArticleId IdType="pubmed">23725553</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramonti F, Bongioanni P, Di Bernardo C, et al. Quality of life of patients with amyotrophic lateral sclerosis. Psychol Health Med. 2012;17:621&#x2013;628. doi: 10.1080/13548506.2011.651149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2011.651149</ArticleId><ArticleId IdType="pubmed">22313252</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau M-C, Pietra S, Blaya J, Catala A. Quality of life of ALS and LIS patients with and without invasive mechanical ventilation. J Neurol. 2011;258:1801&#x2013;1804. doi: 10.1007/s00415-011-6018-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6018-9</ArticleId><ArticleId IdType="pubmed">21461685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28:115&#x2013;119. doi: 10.11138/FNeur/2013.28.2.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2013.28.2.115</ArticleId><ArticleId IdType="pmc">PMC3812727</ArticleId><ArticleId IdType="pubmed">24125561</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CA, Ealing J, McDermott C, et al. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler Front Degener. 2019;20:317&#x2013;327. doi: 10.1080/21678421.2019.1615951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1615951</ArticleId><ArticleId IdType="pubmed">31116037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnini F. Psychological wellbeing and quality of life in amyotrophic lateral sclerosis: a review. Int J Psychol. 2013;48:194&#x2013;205. doi: 10.1080/00207594.2012.691977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207594.2012.691977</ArticleId><ArticleId IdType="pubmed">22731673</ArticleId></ArticleIdList></Reference><Reference><Citation>Linse K, R&#xfc;ger W, Joos M, et al. Eye-tracking&#x2013;based assessment suggests preserved well-being in locked-in patients. Ann Neurol. 2017;81:310&#x2013;315. doi: 10.1002/ana.24871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24871</ArticleId><ArticleId IdType="pubmed">28074605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzma-Kozakiewicz M, Andersen PM, Ciecwierska K, et al. An observational study on quality of life and preferences to sustain life in locked-in state. Neurology. 2019;93:e938&#x2013;e945. doi: 10.1212/WNL.0000000000008064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008064</ArticleId><ArticleId IdType="pmc">PMC6745736</ArticleId><ArticleId IdType="pubmed">31391247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Ehlich B, Lang D, et al. Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol. 2013;260:2836&#x2013;2843. doi: 10.1007/s00415-013-7068-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7068-y</ArticleId><ArticleId IdType="pubmed">23989341</ArticleId></ArticleIdList></Reference><Reference><Citation>Fegg MJ, K&#xf6;gler M, Brandst&#xe4;tter M, et al. Meaning in life in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:469&#x2013;474. doi: 10.3109/17482961003692604.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003692604</ArticleId><ArticleId IdType="pubmed">20235757</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons Z. Patient-Perceived Outcomes and Quality of Life in ALS. Neurotherapeutics. 2015;12:394&#x2013;402. doi: 10.1007/s13311-014-0322-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0322-x</ArticleId><ArticleId IdType="pmc">PMC4404446</ArticleId><ArticleId IdType="pubmed">25502407</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wit J, Bakker LA, van Groenestijn AC, et al. Caregiver burden in amyotrophic lateral sclerosis: A systematic review. Palliat Med. 2018;32:231&#x2013;245. doi: 10.1177/0269216317709965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216317709965</ArticleId><ArticleId IdType="pmc">PMC5784458</ArticleId><ArticleId IdType="pubmed">28671483</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Santangelo G, Trojsi F, et al. Coping strategies and psychological distress in caregivers of patients with Amyotrophic Lateral Sclerosis (ALS) Amyotroph Lateral Scler Front Degener. 2017;18:367&#x2013;377. doi: 10.1080/21678421.2017.1285316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1285316</ArticleId><ArticleId IdType="pubmed">28631956</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M, Gavin T, Mays I, et al. Individual quality of life in spousal ALS patient-caregiver dyads. Health Qual Life Outcomes. 2020;18:371. doi: 10.1186/s12955-020-01551-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01551-5</ArticleId><ArticleId IdType="pmc">PMC7682006</ArticleId><ArticleId IdType="pubmed">33225955</ArticleId></ArticleIdList></Reference><Reference><Citation>Creemers H, de Mor&#xe9;e S, Veldink JH, et al. Factors related to caregiver strain in ALS: a longitudinal study. J Neurol Neurosurg Psychiatry. 2016;87:775&#x2013;781. doi: 10.1136/jnnp-2015-311651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311651</ArticleId><ArticleId IdType="pubmed">26341327</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier A, Vignola A, Calvo A, et al. A longitudinal study on quality of life and depression in ALS patient&#x2013;caregiver couples. Neurology. 2007;68:923&#x2013;926. doi: 10.1212/01.wnl.0000257093.53430.a8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000257093.53430.a8</ArticleId><ArticleId IdType="pubmed">17372127</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wit J, Bakker LA, van Groenestijn AC, et al. Psychological distress and coping styles of caregivers of patients with amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Front Degener. 2019;20:235&#x2013;241. doi: 10.1080/21678421.2018.1534976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1534976</ArticleId><ArticleId IdType="pubmed">30654658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Zoing MC, et al. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12:45&#x2013;51. doi: 10.3109/17482968.2010.520718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.520718</ArticleId><ArticleId IdType="pubmed">20849323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin J, Ogino M, Goetz R, et al. Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Front Degener. 2014;15:185&#x2013;191. doi: 10.3109/21678421.2014.896928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.896928</ArticleId><ArticleId IdType="pubmed">24720451</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson S, Alonso B, Faulkner K, et al. Quality of Life Perspectives of People With Amyotrophic Lateral Sclerosis and Their Caregivers. Am J Occup Ther. 2017;71:7103190010p1. doi: 10.5014/ajot.2017.024828.</Citation><ArticleIdList><ArticleId IdType="doi">10.5014/ajot.2017.024828</ArticleId><ArticleId IdType="pubmed">28422627</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl T, Rupp M, Budde P, et al. Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res. 2011;20:569&#x2013;574. doi: 10.1007/s11136-010-9781-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-010-9781-7</ArticleId><ArticleId IdType="pubmed">21086185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden A, Greenfield D, Nugus P, Kiernan MC. What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Prefer Adherence. 2012;6:829&#x2013;838. doi: 10.2147/PPA.S37851.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PPA.S37851</ArticleId><ArticleId IdType="pmc">PMC3514070</ArticleId><ArticleId IdType="pubmed">23226006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria&#x47f;2015. Amyotroph Lateral Scler Front Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169:13&#x2013;21. doi: 10.1016/s0022-510x(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med. 1995;9:207&#x2013;219. doi: 10.1177/026921639500900306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026921639500900306</ArticleId><ArticleId IdType="pubmed">7582177</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Boyle CA, Browne J, Hickey A, et al. Manual for the SEIQoL-DW. Dublin: Department of Psychology, Royal College of Surgeons in Ireland; 1996.</Citation></Reference><Reference><Citation>Becker G, Merk CS, Meffert C, Momm F. Measuring individual quality of life in patients receiving radiation therapy: the SEIQoL-Questionnaire. Qual Life Res. 2014;23:2025&#x2013;2030. doi: 10.1007/s11136-014-0661-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-014-0661-4</ArticleId><ArticleId IdType="pubmed">24585129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann-Lingen C, Buss U, Snaith RP. Hospital Anxiety and Depression Scale-German Version (HADS-D) Bern: Hans Huber; 2011.</Citation></Reference><Reference><Citation>Ferentinos P, Paparrigopoulos T, Rentzos M, et al. Prevalence of major depression in ALS: Comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler. 2011;12:297&#x2013;302. doi: 10.3109/17482968.2011.556744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.556744</ArticleId><ArticleId IdType="pubmed">21428731</ArticleId></ArticleIdList></Reference><Reference><Citation>Graessel E, Berth H, Lichte T, Grau H. Subjective caregiver burden: validity of the 10-item short version of the Burden Scale for Family Caregivers BSFC-s. BMC Geriatr. 2014;14:23. doi: 10.1186/1471-2318-14-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2318-14-23</ArticleId><ArticleId IdType="pmc">PMC3942019</ArticleId><ArticleId IdType="pubmed">24555474</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2017.</Citation></Reference><Reference><Citation>Goldstein A, Spencer KM, Donchin E. The influence of stimulus deviance and novelty on the P300 and novelty P3. Psychophysiology. 2002;39:781&#x2013;790. doi: 10.1111/1469-8986.3960781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-8986.3960781</ArticleId><ArticleId IdType="pubmed">12462506</ArticleId></ArticleIdList></Reference><Reference><Citation>Herschbach P. The &#x201c;Well-being paradox&#x201d; in quality-of-life research. Psychother Psychosom Med Psychol. 2002;52:141&#x2013;150. doi: 10.1055/s-2002-24953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2002-24953</ArticleId><ArticleId IdType="pubmed">11941521</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgoise SH, Stewart JL, Bremer BA, et al. The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations. Amyotroph Lateral Scler. 2009;10:456&#x2013;462. doi: 10.3109/17482960802444840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802444840</ArticleId><ArticleId IdType="pubmed">19922140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J-S, Moore D, Gordon PH, Miller R. Correlates of quality of life in ALS: Lessons from the minocycline study. Amyotroph Lateral Scler. 2010;11:116&#x2013;121. doi: 10.3109/17482960902918719.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902918719</ArticleId><ArticleId IdType="pubmed">19551536</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke S, Hickey A, O&#x2019;Boyle C, Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res. 2001;10:149&#x2013;158. doi: 10.1023/A:1016704906100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1016704906100</ArticleId><ArticleId IdType="pubmed">11642685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozanne AO, Graneheim UH, Strang S. Finding meaning despite anxiety over life and death in amyotrophic lateral sclerosis patients. J Clin Nurs. 2013;22:2141&#x2013;2149. doi: 10.1111/jocn.12071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.12071</ArticleId><ArticleId IdType="pubmed">23387287</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz CE, Andresen EM, Nosek MA, Krahn GL. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil. 2007;88:529&#x2013;536. doi: 10.1016/j.apmr.2006.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2006.12.032</ArticleId><ArticleId IdType="pubmed">17398257</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa Silva JP, Santiago J&#xfa;nior JB, dos Santos EL, et al. Quality of life and functional independence in amyotrophic lateral sclerosis: a systematic review. Neurosci Biobehav Rev. 2020;111:1&#x2013;11. doi: 10.1016/j.neubiorev.2019.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2019.12.032</ArticleId><ArticleId IdType="pubmed">31917162</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligari M, Godi M, Guglielmetti S, et al. Eye tracking communication devices in amyotrophic lateral sclerosis; impact on disability and quality of life. Amyotroph Lateral Scler Front Degener. 2013;14:546&#x2013;552. doi: 10.3109/21678421.2013.803576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.803576</ArticleId><ArticleId IdType="pubmed">23834069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C-S, Weng H-H, Wang L-F, et al. An eye-tracking assistive device improves the quality of life for ALS patients and reduces the Caregivers&#x2019; burden. J Mot Behav. 2014;46:233&#x2013;238. doi: 10.1080/00222895.2014.891970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00222895.2014.891970</ArticleId><ArticleId IdType="pubmed">24731126</ArticleId></ArticleIdList></Reference><Reference><Citation>Linse K, Aust E, Joos M, Hermann A. Communication matters&#x2014;pitfalls and promise of hightech communication devices in palliative care of severely physically disabled patients with amyotrophic lateral sclerosis. Front Neurol. 2018 doi: 10.3389/fneur.2018.00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00603</ArticleId><ArticleId IdType="pmc">PMC6072854</ArticleId><ArticleId IdType="pubmed">30100896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122&#x2013;123. doi: 10.1212/01.WNL.0000042781.22278.0A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000042781.22278.0A</ArticleId><ArticleId IdType="pubmed">12525733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Hacker S, Ludolph A, et al. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int. 2008;105:397&#x2013;403. doi: 10.3238/arztebl.2008.0397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2008.0397</ArticleId><ArticleId IdType="pmc">PMC2696844</ArticleId><ArticleId IdType="pubmed">19626161</ArticleId></ArticleIdList></Reference><Reference><Citation>Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:243&#x2013;254. doi: 10.1080/17482960701374643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701374643</ArticleId><ArticleId IdType="pubmed">17653923</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead B, O&#x2019;Brien MR, Jack BA, Mitchell D. Experiences of dying, death and bereavement in motor neurone disease: A qualitative study. Palliat Med. 2012;26:368&#x2013;378. doi: 10.1177/0269216311410900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216311410900</ArticleId><ArticleId IdType="pubmed">21712334</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignola A, Guzzo A, Calvo A, et al. Anxiety undermines quality of life in ALS patients and caregivers. Eur J Neurol. 2008;15:1231&#x2013;1236. doi: 10.1111/j.1468-1331.2008.02303.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02303.x</ArticleId><ArticleId IdType="pubmed">18803649</ArticleId></ArticleIdList></Reference><Reference><Citation>Demuru A, Longobardi C, Prino LE, Settanni M. Resilience, anxiety, and depression in amyotrophic lateral sclerosis patients. Psychiatr Psychol Klin-J Psychiatry Clin Psychol. 2019;19:365&#x2013;369. doi: 10.15557/PiPK.2019.0039.</Citation><ArticleIdList><ArticleId IdType="doi">10.15557/PiPK.2019.0039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemoingan J, Ells C. Amyotrophic lateral sclerosis and assisted ventilation: how patients decide. Palliat Support Care. 2010;8:207&#x2013;213. doi: 10.1017/S1478951510000027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951510000027</ArticleId><ArticleId IdType="pubmed">20557668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurt A, Nijboer F, Matuz T, K&#xfc;bler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis. CNS Drugs. 2007;21:279&#x2013;291. doi: 10.2165/00023210-200721040-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00023210-200721040-00003</ArticleId><ArticleId IdType="pubmed">17381183</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Elamin M, Galvin M, et al. Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. J Neurol. 2015;262:1526&#x2013;1532. doi: 10.1007/s00415-015-7746-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7746-z</ArticleId><ArticleId IdType="pubmed">25904206</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozanne AO, Graneheim UH, Strang S. Struggling to find meaning in life among spouses of people with ALS. Palliat Support Care. 2015;13:909&#x2013;916. doi: 10.1017/S1478951514000625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1478951514000625</ArticleId><ArticleId IdType="pubmed">24991842</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;connor EJ, McCabe MP, Firth L. The impact of neurological illness on marital relationships. J Sex Marital Ther. 2008;34:115&#x2013;132. doi: 10.1080/00926230701636189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00926230701636189</ArticleId><ArticleId IdType="pubmed">18224547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandstedt P, Littorin S, Widsell GC, et al. Caregiver experience, health-related quality of life and life satisfaction among informal caregivers to patients with amyotrophic lateral sclerosis: a cross-sectional study. J Clin Nurs. 2018;27:4321&#x2013;4330. doi: 10.1111/jocn.14593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.14593</ArticleId><ArticleId IdType="pubmed">29964322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg MB, Forshew DA. Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology. 2002;58:320&#x2013;322. doi: 10.1212/WNL.58.2.320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.2.320</ArticleId><ArticleId IdType="pubmed">11805269</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert SM, Rabkin JG, Bene MLD, et al. Wish to die in end-stage ALS. Neurology. 2005;65:68&#x2013;74. doi: 10.1212/01.wnl.0000168161.54833.bb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000168161.54833.bb</ArticleId><ArticleId IdType="pmc">PMC1201540</ArticleId><ArticleId IdType="pubmed">16009887</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutzki R, Weber M, Reiter-Theil S, et al. Attitudes towards hastened death in ALS: a prospective study of patients and family caregivers. Amyotroph Lateral Scler Front Degener. 2014;15:68&#x2013;76. doi: 10.3109/21678421.2013.837928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.837928</ArticleId><ArticleId IdType="pubmed">24070371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettemann D, Funke A, Maier A, et al. Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation. Amyotroph Lateral Scler Front Degener. 2017;18:53&#x2013;59. doi: 10.1080/21678421.2016.1214734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1214734</ArticleId><ArticleId IdType="pubmed">27534566</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho-&#xd6;zhan HEA, B&#xf6;hm S, Keller J, et al. Experience matters: neurologists&#x2019; perspectives on ALS patients&#x2019; well-being. J Neurol. 2017;264:639&#x2013;646. doi: 10.1007/s00415-016-8382-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8382-y</ArticleId><ArticleId IdType="pubmed">28120043</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>